James A Hendrix Selected Research

Histamine H3 Antagonists

6/2013	Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).
6/2013	Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James A Hendrix Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 07/2015
4	Dementia (Dementias) 01/2018 - 07/2015
2	Obesity 06/2013 - 06/2013
1	Down Syndrome (Down's Syndrome) 04/2021
1	Disease Progression 01/2018
1	Neuroinflammatory Diseases 06/2016
1	Sleep Wake Disorders 11/2013

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 04/2021 - 07/2015
2	Pharmaceutical PreparationsIBA 01/2017 - 07/2015
2	Histamine H3 AntagonistsIBA 06/2013 - 06/2013
2	AmidesIBA 06/2013 - 06/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 11/2013
1	tetrahydro-pyran-4-carboxylic acid (2- methyl- 4- (2- methyl- (1,3')bipyrrolidinyl- 1'- yl)phenyl)amideIBA 11/2013

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2016
1	Wearable Electronic Devices 01/2018
1	Institutionalization (Institutionalized Persons) 09/2017